124 related articles for article (PubMed ID: 11839569)
1. Cytokeratins as targets for bile acid-induced toxicity.
Fickert P; Trauner M; Fuchsbichler A; Stumptner C; Zatloukal K; Denk H
Am J Pathol; 2002 Feb; 160(2):491-9. PubMed ID: 11839569
[TBL] [Abstract][Full Text] [Related]
2. Bile acid-induced Mallory body formation in drug-primed mouse liver.
Fickert P; Trauner M; Fuchsbichler A; Stumptner C; Zatloukal K; Denk H
Am J Pathol; 2002 Dec; 161(6):2019-26. PubMed ID: 12466118
[TBL] [Abstract][Full Text] [Related]
3. The role of the hepatocyte cytokeratin network in bile formation and resistance to bile acid challenge and cholestasis in mice.
Fickert P; Fuchsbichler A; Wagner M; Silbert D; Zatloukal K; Denk H; Trauner M
Hepatology; 2009 Sep; 50(3):893-9. PubMed ID: 19585611
[TBL] [Abstract][Full Text] [Related]
4. Mallory body formation in primary biliary cirrhosis is associated with increased amounts and abnormal phosphorylation and ubiquitination of cytokeratins.
Fickert P; Trauner M; Fuchsbichler A; Stumptner C; Zatloukal K; Denk H
J Hepatol; 2003 Apr; 38(4):387-94. PubMed ID: 12663227
[TBL] [Abstract][Full Text] [Related]
5. Effects of ursodeoxycholic and cholic acid feeding on hepatocellular transporter expression in mouse liver.
Fickert P; Zollner G; Fuchsbichler A; Stumptner C; Pojer C; Zenz R; Lammert F; Stieger B; Meier PJ; Zatloukal K; Denk H; Trauner M
Gastroenterology; 2001 Jul; 121(1):170-83. PubMed ID: 11438506
[TBL] [Abstract][Full Text] [Related]
6. Pathologic changes in the cytokeratin pericanalicular sheath in experimental cholestasis and alcoholic fatty liver.
Ohta M; Marceau N; French SW
Lab Invest; 1988 Jul; 59(1):60-74. PubMed ID: 2455832
[TBL] [Abstract][Full Text] [Related]
7. Modifications in cytokeratin and actin in cultured liver cells derived from griseofulvin-fed mice.
Cadrin M; Anderson NM; Aasheim LH; Kawahara H; Franks DJ; French SW
Lab Invest; 1995 Apr; 72(4):453-60. PubMed ID: 7536860
[TBL] [Abstract][Full Text] [Related]
8. Serotonin protects mouse liver from cholestatic injury by decreasing bile salt pool after bile duct ligation.
Jang JH; Rickenbacher A; Humar B; Weber A; Raptis DA; Lehmann K; Stieger B; Moritz W; Soll C; Georgiev P; Fischer D; Laczko E; Graf R; Clavien PA
Hepatology; 2012 Jul; 56(1):209-18. PubMed ID: 22290718
[TBL] [Abstract][Full Text] [Related]
9. Induction of short heterodimer partner 1 precedes downregulation of Ntcp in bile duct-ligated mice.
Zollner G; Fickert P; Silbert D; Fuchsbichler A; Stumptner C; Zatloukal K; Denk H; Trauner M
Am J Physiol Gastrointest Liver Physiol; 2002 Jan; 282(1):G184-91. PubMed ID: 11751172
[TBL] [Abstract][Full Text] [Related]
10. Oncosis represents the main type of cell death in mouse models of cholestasis.
Fickert P; Trauner M; Fuchsbichler A; Zollner G; Wagner M; Marschall HU; Zatloukal K; Denk H
J Hepatol; 2005 Mar; 42(3):378-85. PubMed ID: 15710221
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of intermediate filaments in the process of developing hepatic steatosis.
Park JE; Kim HT; Lee S; Lee YS; Choi UK; Kang JH; Choi SY; Kang TC; Choi MS; Kwon OS
Proteomics; 2011 Jul; 11(14):2777-89. PubMed ID: 21674798
[TBL] [Abstract][Full Text] [Related]
12. Metabolism and effects on cholestasis of isoursodeoxycholic and ursodeoxycholic acids in bile duct ligated rats.
Purucker E; Marschall HU; Winograd R; Matern S
Biochim Biophys Acta; 2001 Apr; 1526(1):44-52. PubMed ID: 11287121
[TBL] [Abstract][Full Text] [Related]
13. Cytokeratin patterns of liver carcinomas induced by diethylnitrosamine in monkeys.
Lapis K; Sarosi I; Bocsi J; Thorgeirsson UP
Lab Invest; 1995 Jun; 72(6):748-59. PubMed ID: 7540236
[TBL] [Abstract][Full Text] [Related]
14. Excretory function in cultured hepatocytes from griseofulvin-treated mice.
Kawahara H; Marceau N; French SW
Lab Invest; 1989 Dec; 61(6):609-22. PubMed ID: 2481150
[TBL] [Abstract][Full Text] [Related]
15. Conjugation is essential for the anticholestatic effect of NorUrsodeoxycholic acid in taurolithocholic acid-induced cholestasis in rat liver.
Denk GU; Maitz S; Wimmer R; Rust C; Invernizzi P; Ferdinandusse S; Kulik W; Fuchsbichler A; Fickert P; Trauner M; Hofmann AF; Beuers U
Hepatology; 2010 Nov; 52(5):1758-68. PubMed ID: 21038414
[TBL] [Abstract][Full Text] [Related]
16. Regulation of rat organic anion transporters in bile salt-induced cholestatic hepatitis: effect of ursodeoxycholate.
Rost D; Herrmann T; Sauer P; Schmidts HL; Stieger B; Meier PJ; Stremmel W; Stiehl A
Hepatology; 2003 Jul; 38(1):187-95. PubMed ID: 12830001
[TBL] [Abstract][Full Text] [Related]
17. Expression and antioxidant function of liver fatty acid binding protein in normal and bile-duct ligated rats.
Wang G; Shen H; Rajaraman G; Roberts MS; Gong Y; Jiang P; Burczynski F
Eur J Pharmacol; 2007 Mar; 560(1):61-8. PubMed ID: 17292345
[TBL] [Abstract][Full Text] [Related]
18. Long-term effect of treating pregnant rats with ursodeoxycholic acid on the congenital impairment of bile secretion induced in the pups by maternal cholestasis.
Macias RI; Serrano MA; Monte MJ; Jimenez S; Hernandez B; Marin JJ
J Pharmacol Exp Ther; 2005 Feb; 312(2):751-8. PubMed ID: 15452192
[TBL] [Abstract][Full Text] [Related]
19. Biliary secretion and actin-cytokeratin filament distribution in rat hepatocytes during phalloidin-induced cholestasis.
Loranger A; Tuchweber B; Youseff I; Marceau N
Biochem Cell Biol; 1995; 73(9-10):641-9. PubMed ID: 8714684
[TBL] [Abstract][Full Text] [Related]
20. Ductular reaction at the early terms of common bile duct ligation in the rats.
Azmaiparashvili E; Berishvili E; Kakabadze Z; Pilishvili O; Mikautadze E; Solomonia R; Jangavadze M; Kordzaia D
Acta Biol Hung; 2012 Sep; 63(3):321-32. PubMed ID: 22963913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
